Outlook Therapeutics, Inc. (OTLK) NASDAQ
0.24
-0.0052(-2.10%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.24
-0.0052(-2.10%)
Currency In USD
| Market Cap | 36.88M |
| Enterprise Value | 59M |
| P/E Ratio | -0.14 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 48.54 |
| Price/Book Ratio | -0.38 |
| Enterprise/Revenue | 185.82 |
| Enterprise/EBITDA | -0.63 |
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -500.45 |
| Operating Margin | -286.76 |
| Return On Assets | -5.64 |
| Return On Equity | 2.93 |
| Revenue | 1.41M |
| Revenue/Share | 0 |
| Gross Profit | 657,205 |
| EBITDA | -63.58M |
| Net Income | -62.42M |
| Diluted EPS | -1.79 |
| Total Cash | 8.68M |
| Total Cash/Share | 0.14 |
| Total Debt | 36.89M |
| Total Debt/Equity | -0.96 |
| Current Ratio | 0.35 |
| Book Value Per Share | -0.64 |
| 52-Week Change | -88.05 |
| 52-Week High | 3.39 |
| 52-Week Low | 0.16 |
| Moving Average 50 Days | 0.29 |
| Moving Average 200 Days | 1.05 |
| Average Volume | 3.71M |
| Shares Outstanding | 41.14M |
| % Held by Institutions | 11.33 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | March 14, 2024 |